SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-027635
Filing Date
2015-05-05
Accepted
2015-05-05 16:31:01
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v408003_10q.htm 10-Q 353481
2 CERTIFICATION v408003_ex31-1.htm EX-31.1 11181
3 CERTIFICATION v408003_ex31-2.htm EX-31.2 10890
4 CERTIFICATION v408003_ex32-1.htm EX-32.1 6783
  Complete submission text file 0001144204-15-027635.txt   4597754

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20150331.xml EX-101.INS 661394
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20150331.xsd EX-101.SCH 36906
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20150331_cal.xml EX-101.CAL 42302
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20150331_def.xml EX-101.DEF 253380
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20150331_lab.xml EX-101.LAB 289329
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20150331_pre.xml EX-101.PRE 287882
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 15833436
SIC: 2834 Pharmaceutical Preparations